2021 Sponsors

We couldn’t continue to run The Student Voice Prize essay competition without the help of our generous sponsors.

Without them, there’d be no us!

Get to know our wonderful 2021 sponsors below and check out the incredible work they’re doing in the medical and scientific fields!

Gold Sponsors

Linguamatics

Linguamatics, an IQVIA company, is the proud creator of the market-leading Natural Language Processing-based (NLP) artificial intelligence (AI) platform that’s used by 19 of the top 20 global pharmaceutical companies and the US Food and Drug Administration (FDA).

Their AI platform helps pharmaceutical, biotechnology, healthcare, government and academia organisations gain insights from the textual data they collect so that they can make the best decisions possible.

Linguamatics’ AI platform is used to help accelerate the drug development process by breaking down data silos and decreasing the risk and complexity associated with textual data analysis and understanding. It’s why they’ve been trusted for over 15 years to deliver actionable insights for their clients!

Fun Fact: Every week they hold a picture caption competition internally with the winner taking home chocolates of their choice. They’ve even managed to keep it going through remote working, albeit with no chocolate for now.

EUSA Pharma

OUR MISSION: HELPING PATIENTS TO LIVE AND EMBRACE LIFE BY MAKING OUR PRODUCTS AVAILABLE GLOBALLY

EUSA Pharma is a dynamic, global biopharmaceutical company focused on oncology and rare disease, continuously striving to confront gaps in patient care. As a global biopharmaceutical company, EUSA is committed to deliver solutions that can have a meaningful effect on life, helping patients across a range of therapy areas.

Founded in 2015, we are continuously looking for new opportunities to confront current gaps in patient care. Our ambition and entrepreneurial culture drive us to explore, acquire and in-license products that we believe can bring about real change for patients.

Silver Sponsors

Costello Medical works to improve healthcare by providing clients with scientific support in the analysis, interpretation and communication of clinical and health economic data.

The Rare Diseases Division at Costello Medical are dedicated to understanding the unique challenges faced by the rare diseases community, and developing strategies to overcome the difficulties faced when there is little clinical or health economic evidence available, poor understanding and awareness of a rare condition and a need to accelerate access for patients to potentially life-saving drugs.

Their experience supporting the healthcare industry in rare diseases includes working across a wide range of indications including rare oncology, paediatric diseases and genetic conditions.

Fun Fact: Costello Medical created the official new logo, branding and video for The Student Voice Prize on a pro bono basis! For more information please visit their website.

tranScrip is an innovative UK-based provider of specialist professional services, supporting the drug development and lifecycle management activities of pharmaceutical and biotechnology companies.

A global leader in the Specialist Service Sector, tranScrip delivers both strategic leadership and operational support to clients from pre-clinical through to commercialisation.

tranScrip has extensive experience working within the rare disease space. They have assisted in the design and delivery of large, complex, cross-functional rare disease programmes, across a wide spectrum of therapy areas and diseases, including gene therapy, cell therapy and tissue engineering.

Fun Fact: Every year, tranScrip’s Partners and employees use their skills, interests and talents in a wide variety of ways for the benefit of charities and the enrichment of their communities and beyond. Activities range from transforming gardens for children with disabilities to sponsored sailing.

Dolon is a strategic pricing and market access consultancy that specialises in rare and severe diseases. We have in-depth knowledge of reimbursement pathways, payer perspectives and evidence requirements and we help companies navigate the system to ensure patients can gain access to rare disease treatments. Dolon also works with a wide range of stakeholders to shape policy and draw attention to the challenges affecting development, continued investment and access to new treatments for rare diseases.

Fun Fact: At Dolon, we are a small but very international team. We have 40 staff (and growing) with 20 nationalities spread across 10 countries!